Updated consensus guidelines on the management of Phelan–McDermid syndrome

Author:

Srivastava Siddharth12ORCID,Sahin Mustafa12,Buxbaum Joseph D.3456,Berry‐Kravis Elizabeth789,Soorya Latha Valluripalli10,Thurm Audrey11,Bernstein Jonathan A.12ORCID,Asante‐Otoo Afua13,Bennett William E.14,Betancur Catalina15,Brickhouse Tegwyn H.16,Passos Bueno Maria Rita17,Chopra Maya12,Christensen Celanie K.1819,Cully Jennifer L.20,Dies Kira12,Friedman Kate34,Gummere Brittany21,Holder J. Lloyd22,Jimenez‐Gomez Andres23,Kerins Carolyn A.24,Khan Omar25,Kohlenberg Teresa26,Lacro Ronald V.27,Levi Lori A.28,Levy Tess3,Linnehan Diane29,Eva Loth30,Moshiree Baharak31,Neumeyer Ann32,Paul Scott M.13,Phelan Katy33,Persico Antonio34,Rapaport Robert35,Rogers Curtis36,Saland Jeffrey35,Sethuram Swathi37,Shapiro Janine38,Tarr Phillip I.39,White Kerry M.1840,Wickstrom Jordan41,Williams Kent M.42,Winrow Dana43,Wishart Brian44,Kolevzon Alexander3435

Affiliation:

1. Department of Neurology Boston Children's Hospital Boston Massachusetts USA

2. Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital Harvard Medical School Boston Massachusetts USA

3. Seaver Autism Center for Research and Treatment Icahn School of Medicine at Mount Sinai New York New York USA

4. Department of Psychiatry Icahn School of Medicine at Mount Sinai New York New York USA

5. Department of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai New York New York USA

6. Department of Neuroscience Icahn School of Medicine at Mount Sinai New York New York USA

7. Department of Pediatrics Rush University Medical Center Chicago Illinois USA

8. Department of Neurological Sciences Rush University Medical Center Chicago Illinois USA

9. Department of Biochemistry Rush University Medical Center Chicago Illinois USA

10. Department of Psychiatry and Behavioral Sciences Rush University Medical Center Chicago Illinois USA

11. Neurodevelopmental and Behavioral Phenotyping Service, National Institute of Mental Health National Institutes of Health Bethesda Maryland USA

12. Department of Pediatrics Stanford University School of Medicine Stanford California USA

13. Rehabilitation Medicine Department NIH Clinical Center Bethesda Maryland USA

14. Department of Pediatrics Indiana University School of Medicine Indianapolis Indiana USA

15. Sorbonne Université, INSERM, CNRS, Neuroscience Paris Seine Institut de Biologie Paris Seine Paris France

16. Department of Dental Public Health & Policy, School of Dentistry Virginia Commonwealth University Richmond Virginia USA

17. Departamento de Genética e Biologia Evolutiva, Centro de Estudos do Genoma Humano e Células‐tronco Instituto de Biociências, Universidade de São Paulo São Paulo Brazil

18. Division of Developmental Medicine, Department of Pediatrics Riley Children's Health Indianapolis Indiana USA

19. Division of Child Neurology, Department of Neurology Riley Children's Health Indianapolis Indiana USA

20. Department of Pediatrics, College of Medicine and Division of Dentistry and Orthodontics, University of Cincinnati Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

21. Indiana University Indianapolis Indiana USA

22. Department of Pediatrics‐Neurology Baylor College of Medicine Houston Texas USA

23. Joe DiMaggio Children's Hospital Hollywood Florida USA

24. Department of Pediatric Dentistry, School of Dentistry Texas A&M University Dallas Texas USA

25. National Institute of Neurological Disease and Stroke Bethesda Maryland USA

26. University of Massachusetts Chan Medical School Worcester Massachusetts USA

27. Department of Cardiology, Boston Children's Hospital, Department of Pediatrics Harvard Medical School Boston Massachusetts USA

28. University of Southern California Arcadia California USA

29. Phelan‐McDermid Syndrome Foundation Osprey Florida USA

30. Kings College London London UK

31. Department of Medicine Wake Forest/Atrium Health Charlotte North Carolina USA

32. Lurie Center for Autism, Massachusetts General Hospital, Lexington, Massachusetts, USA Harvard Medical School Boston Massachusetts USA

33. Genetics Laboratory Florida Cancer Specialists and Research Institute Fort Myers Florida USA

34. Department of Biomedical, Metabolic and Neural Sciences University of Modena and Reggio Emilia Modena Italy

35. Department of Pediatrics, Kravis Children's Hospital Icahn School of Medicine at Mount Sinai New York New York USA

36. RCR Genetics Greer South Carolina USA

37. Department of Pediatrics Massachusetts General Hospital Boston Massachusetts USA

38. Access Behavior Analysis Indianapolis Indiana USA

39. Department of Pediatrics Washington University School of Medicine St. Louis Missouri USA

40. Department of Medical and Molecular Genetics Riley Children's Health Indianapolis Indiana USA

41. Sinai Rehabilitation Center Lifebridge Health Baltimore Maryland USA

42. Department of Pediatrics The Ohio State University School of Medicine Columbus Ohio USA

43. Emerson Health Concord Massachusetts USA

44. Massachusetts General Hospital Boston Massachusetts USA

Abstract

AbstractPhelan–McDermid syndrome (PMS) is a genetic condition caused by SHANK3 haploinsufficiency and characterized by a wide range of neurodevelopmental and systemic manifestations. The first practice parameters for assessment and monitoring in individuals with PMS were published in 2014; recently, knowledge about PMS has grown significantly based on data from longitudinal phenotyping studies and large‐scale genotype–phenotype investigations. The objective of these updated clinical management guidelines was to: (1) reflect the latest in knowledge in PMS and (2) provide guidance for clinicians, researchers, and the general community. A taskforce was established with clinical experts in PMS and representatives from the parent community. Experts joined subgroups based on their areas of specialty, including genetics, neurology, neurodevelopment, gastroenterology, primary care, physiatry, nephrology, endocrinology, cardiology, gynecology, and dentistry. Taskforce members convened regularly between 2021 and 2022 and produced specialty‐specific guidelines based on iterative feedback and discussion. Taskforce leaders then established consensus within their respective specialty group and harmonized the guidelines. The knowledge gained over the past decade allows for improved guidelines to assess and monitor individuals with PMS. Since there is limited evidence specific to PMS, intervention mostly follows general guidelines for treating individuals with developmental disorders. Significant evidence has been amassed to guide the management of comorbid neuropsychiatric conditions in PMS, albeit mainly from caregiver report and the experience of clinical experts. These updated consensus guidelines on the management of PMS represent an advance for the field and will improve care in the community. Several areas for future research are also highlighted and will contribute to subsequent updates with more refined and specific recommendations as new knowledge accumulates.

Funder

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Center for Advancing Translational Sciences

National Institute of Mental Health

National Institute of Neurological Disorders and Stroke

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Reference137 articles.

1. Diagnosis of metachromatic leukodystrophy in a patient with regression and Phelan-McDermid syndrome

2. American Academy of Pediatric Dentistry. (2022a). Management of dental patients with special health care needs. InThe reference manual of pediatric dentistry(pp. 302–329). American Academy of Pediatric Dentistry.

3. American Academy of Pediatric Dentistry. (2022b). Policy on third‐party reimbursement for management of patients with special health care needs. InThe reference manual of pediatric dentistry(pp. 152–155). American Academy of Pediatric Dentistry.

4. Policy on third‐party reimbursement for Management of Patients with special health care needs;Anonymous;Pediatric Dentistry,2018

5. Neurofibromatosis Type 2

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3